SUBCLINICAL ATHEROSCLEROSIS EVOLUTION IN PSORIATIC ARTHRITIS PATIENTS TREATED WITH ANTI-TNF ALPHA: 5 YEARS FOLLOW UP

被引：0
|
作者：
Ortolan, A. [1 ]
Puato, M. [2 ]
Boschetti, G. [2 ]
Lorenzin, M. [1 ]
Hoxha, A. [1 ]
Punzi, L. [1 ]
Ramonda, R. [1 ]
机构：
[1] Univ Padua, Dept Med DIMED, Rheumatol Unit, Padua, Italy
[2] Univ Padua, Dept Med DIMED, Clin Med 3, Padua, Italy
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2017年 / 76卷
关键词：
D O I：
10.1136/annrheumdis-2017-eular.5545
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
AB0745
引用
收藏
页码：1315 / 1316
页数：2
相关论文
共 50 条
  • [31] Autoantibody formation in patients with rheumatoid arthritis treated with anti-TNFα
    Eriksson, C
    Engstrand, S
    Sundqvist, KG
    Rantapää-Dahlqvist, S
    ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 (03) : 403 - 407
  • [32] Varicella zoster virus encephalopathy in a patient with psoriatic arthritis treated with anti-TNFα agents
    Takuya Miyagi
    Sayaka Yamaguchi
    Yu-ichi Yamamoto
    Aoi Ohira
    Ryo Yasumura
    Naoko Nakasone
    Hiroshi Uezato
    Kenzo Takahashi
    European Journal of Dermatology, 2014, 24 : 398 - 399
  • [33] Varicella zoster virus encephalopathy in a patient with psoriatic arthritis treated with anti-TNFα agents
    Miyagi, Takuya
    Yamaguchi, Sayaka
    Yamamoto, Yu-ichi
    Ohira, Aoi
    Yasumura, Ryo
    Nakasone, Naoko
    Uezato, Hiroshi
    Takahashi, Kenzo
    EUROPEAN JOURNAL OF DERMATOLOGY, 2014, 24 (03) : 398 - 399
  • [34] IMPACT OF ANTI-TNFALPHA THERAPY ON SUBCLINICAL ATHEROSCLEROSIS IN PATIENTS WITH PSORIATIC ARTHRITIS
    Puato, M.
    Zanardo, M.
    Ramonda, R.
    Faggin, E.
    Zanon, M.
    Balbi, G.
    Lo Nigro, A.
    Rattazzi, M.
    Doria, A.
    Pauletto, P.
    ATHEROSCLEROSIS SUPPLEMENTS, 2011, 12 (01) : 81 - 81
  • [35] Adverse Dermatological Reactions in Rheumatoid Arthritis Patients Treated with Etanercept, an Anti-TNF alpha Drug
    Rajakulendran, Shyra
    Deighton, Chris
    CURRENT DRUG SAFETY, 2006, 1 (03) : 259 - 264
  • [36] Polymorphisms associated with anti-TNF drugs response in patients with psoriasis and psoriatic arthritis
    Ovejero-Benito, M. C.
    Munoz-Aceituno, E.
    Reolid, A.
    Fisas, L. H.
    Llamas-Velasco, M.
    Prieto-Perez, R.
    Abad-Santos, F.
    Dauden, E.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2019, 33 (04) : E175 - E177
  • [37] Treatment patterns and costs for anti-TNFα biologic therapy in patients with psoriatic arthritis
    Palmer, Jacqueline B.
    Li, Yunfeng
    Herrera, Vivian
    Liao, Minlei
    Tran, Melody
    Ozturk, Zafer E.
    BMC MUSCULOSKELETAL DISORDERS, 2016, 17
  • [38] Treatment patterns and costs for anti-TNFα biologic therapy in patients with psoriatic arthritis
    Jacqueline B. Palmer
    Yunfeng Li
    Vivian Herrera
    Minlei Liao
    Melody Tran
    Zafer E. Ozturk
    BMC Musculoskeletal Disorders, 17
  • [39] Thalassemic Trait Prevalence in Patients Affected by Psoriatic Arthritis in Anti-TNF Treatment
    Atteno, Mariangela
    Costa, Luisa
    Vitiello, Maria
    Caso, Francesco
    Sarnelli, Giovanni
    Del Puente, Antonio
    Scarpa, Raffaele
    DRUG DEVELOPMENT RESEARCH, 2014, 75 : S20 - S22
  • [40] Long-term follow-up of patients treated with infliximab (anti-TNF alpha antibody) in clinical trials.
    Kavanaugh, A
    Schaible, T
    DeWoody, K
    Marsters, P
    Dittrich, K
    Harriman, G
    ARTHRITIS AND RHEUMATISM, 1999, 42 (09): : S401 - S401
12345